Understand the source comparison
DSIP vs GLP-1 Peptides, Growth Hormone Secretagogues, and Nootropics: Comparison
Researchers selecting peptides for specific physiological targets often compare DSIP to other neuroactive compounds. Here's how they differ across mechanism, primary research use, and practical constraints. DSIP CRH/ACTH modulation; delta-wave amplitude regula
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers selecting peptides for specific physiological targets often compare DSIP to other neuroactive compounds. Here's how they differ across mechanism, primary research use, and practical constraints.
- DSIP
- CRH/ACTH modulation; delta-wave amplitude regulation
- Sleep architecture, stress-induced oxidative damage, opioid withdrawal
- −20°C powder; 2–8°C reconstituted; 28-day shelf life
- Subcutaneous, intravenous (intranasal shows 40–60% lower bioavailability)
- Best for stress-modulated sleep disruption and acute withdrawal protocols. Not chronic insomnia
- GHK-Cu
- Copper peptide complex; collagen synthesis activation
- Wound healing, tissue remodelling, anti-inflammatory research
- −20°C powder; 2–8°C reconstituted; 14-day shelf life
- Topical, subcutaneous
- Primarily dermatological and tissue repair applications. No sleep or stress effects
- Selank
- Anxiety modulation via BDNF upregulation
- Anxiolytic research, cognitive performance under stress
- Stable at room temperature for 60 days reconstituted
- Intranasal (80% bioavailability)
- Anxiolytic with minimal sedation. Does not alter sleep architecture
- Cerebrolysin
- Neurotrophic peptide mixture; neuroprotection
- Stroke recovery, traumatic brain injury, cognitive decline
- 2–8°C (pre-mixed injectable); 36-month shelf life sealed
- Intravenous only
- Neuroprotective rather than neuromodulatory. Targets neurogenesis, not sleep cycles
- Epitalon
- Telomerase activation; pineal gland regulation
- Circadian rhythm research, anti-aging models
- −20°C powder; 2–8°C reconstituted; 21-day shelf life
- Subcutaneous
- Melatonin modulation via pineal function. Shifts circadian phase but does not enhance delta waves
- DSIP's advantage in stress-modulated insomnia research is its lack of next-day sedation or REM suppression. Benzodiazepines and Z-drugs suppress slow-wave sleep while extending total sleep time. The exact opposite of DSIP's profile. For research models involving acute stress or withdrawal, DSIP's CRH inhibition offers a mechanistic target that sedative-hypnotics do not address.